In addition, YTHDF2 overexpression predicted poor outcomes in lung cancer patients (Figure 6—figure supplement 1E; Rousseaux et al., 2013; Goswami and Nakshatri, 2014). This evidence concerns the gene YTHDF2 and lung carcinoma.